~~<i id='7EB613A849'><strike id='7EB613A849'><tt id='7EB613A849'><pre id='7EB613A849'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-09-28 21:19:09 Page View：175

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare Advantage plans can’t deny care with AI, CMS warns
Next article： In age of alternative facts, a scholarly course on calling out crap

focus

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Gene therapy for Afghan refugees’ infant will be fully covered

ThePeshaichildren(fromleft):Abubakar,Mohammad,andSufyan.Illustration:STAT;PhotoCourtesyAfteramonths-

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

AstraZeneca stays mum on Medicare drug pricing negotiations

AstraZenecaCEOPascalSoriotJacquelynMartin/APLONDON—Medicare’sfirst-everdrugpricingnegotiationsareoff